Rapid Micro Biosystems Inc
NASDAQ:RPID
Balance Sheet
Balance Sheet Decomposition
Rapid Micro Biosystems Inc
Rapid Micro Biosystems Inc
Balance Sheet
Rapid Micro Biosystems Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
13
|
30
|
178
|
27
|
24
|
17
|
|
| Cash Equivalents |
13
|
30
|
178
|
27
|
24
|
17
|
|
| Short-Term Investments |
0
|
15
|
15
|
82
|
68
|
34
|
|
| Total Receivables |
5
|
6
|
6
|
6
|
6
|
8
|
|
| Accounts Receivables |
4
|
6
|
5
|
6
|
6
|
8
|
|
| Other Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
6
|
9
|
16
|
21
|
20
|
20
|
|
| Other Current Assets |
1
|
2
|
3
|
3
|
3
|
2
|
|
| Total Current Assets |
24
|
62
|
218
|
139
|
120
|
81
|
|
| PP&E Net |
8
|
7
|
11
|
21
|
19
|
16
|
|
| PP&E Gross |
8
|
7
|
11
|
21
|
19
|
16
|
|
| Accumulated Depreciation |
9
|
10
|
12
|
12
|
14
|
17
|
|
| Long-Term Investments |
0
|
0
|
10
|
30
|
3
|
0
|
|
| Other Long-Term Assets |
1
|
1
|
2
|
1
|
1
|
1
|
|
| Total Assets |
32
N/A
|
70
+121%
|
241
+245%
|
191
-21%
|
143
-25%
|
98
-32%
|
|
| Liabilities | |||||||
| Accounts Payable |
3
|
5
|
4
|
5
|
2
|
3
|
|
| Accrued Liabilities |
5
|
6
|
10
|
8
|
11
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
2
|
5
|
4
|
5
|
6
|
7
|
|
| Total Current Liabilities |
11
|
16
|
18
|
19
|
19
|
18
|
|
| Long-Term Debt |
18
|
25
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
4
|
5
|
2
|
7
|
6
|
5
|
|
| Total Liabilities |
32
N/A
|
45
+40%
|
20
-55%
|
27
+31%
|
25
-4%
|
23
-10%
|
|
| Equity | |||||||
| Common Stock |
82
|
152
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
205
|
242
|
315
|
376
|
428
|
475
|
|
| Additional Paid In Capital |
122
|
115
|
536
|
541
|
546
|
550
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Equity |
1
N/A
|
25
N/A
|
221
+791%
|
164
-26%
|
118
-28%
|
75
-36%
|
|
| Total Liabilities & Equity |
32
N/A
|
70
+121%
|
241
+245%
|
191
-21%
|
143
-25%
|
98
-32%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
40
|
40
|
42
|
42
|
42
|
43
|
|